AAPL
59
3
PSX
40
3
DIS
72
14
MRK
35
2
SWKS
40
4
LB
57
2
TSCO
39
-5
INTC
29
5
EW
44
15
HAS
59
11
MCK
75
-2
AXP
63
3
LOW
53
4
FE
67
-2
PAYX
51
4
EXR
48
2
PVH
52
13
MHK
58
10
COST
45
-2
PEP
33
-6
AAPL
59
3
PSX
40
3
DIS
72
14
MRK
35
2
SWKS
40
4
LB
57
2
TSCO
39
-5
INTC
29
5
EW
44
15
HAS
59
11
MCK
75
-2
AXP
63
3
LOW
53
4
FE
67
-2
PAYX
51
4
EXR
48
2
PVH
52
13
MHK
58
10
COST
45
-2
PEP
33
-6
Financhill
Back

Stellantis NV Vs. SpringWorks Therapeutics Industry Stock Comparison

Sell
28

STLA
Stellantis NV

Last Price:
$9.42
Seasonality Move:
-1.15%
Buy
57

SWTX
SpringWorks Therapeutics

Last Price:
$44.75
Seasonality Move:
5.38%
Sell
28
Stellantis NV (STLA) is a Sell

Is Stellantis NV a Buy, Sell or Hold?

  • The current Stellantis NV [STLA] share price is $9.33. The Score for STLA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • STLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
SpringWorks Therapeutics (SWTX) is a Buy

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $44.93. The Score for SWTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

STLA Stock Price Chart

What is Stellantis NV's stock price today?

  • The Stellantis NV share price today is $9.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $44.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

STLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 40.78 Sell
Chaikin Money Flow: 10444644 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.04 - 11.58) Sell
Bollinger Bands (100): (10.94 - 13.78) Sell

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 56.56 Buy
Chaikin Money Flow: 4909709 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.96 - 46.88) Buy
Bollinger Bands (100): (35.71 - 50.27) Buy

STLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.3 Buy
20-day SMA: 9.84 Sell
50-day SMA: 11.65 Sell
200-day SMA: 13.96 Sell
8-day EMA: 9.32 Buy
20-day EMA: 9.91 Sell
50-day EMA: 11.1 Sell
200-day EMA: 14.11 Sell

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.3 Buy
20-day SMA: 40.24 Buy
50-day SMA: 47.8 Sell
200-day SMA: 39.22 Buy
8-day EMA: 40.31 Buy
20-day EMA: 41.05 Buy
50-day EMA: 43.25 Buy
200-day EMA: 40.86 Buy

Stellantis NV Earnings Growth & STLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $1.15 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $2.02 per share.

Stellantis NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):